Treatment of Refractory Neurosarcoidosis with Cladribine
NEJM 350:1798-1799, Tikoo,R.K.,et al, 2004
Clinicopath Conf., Progessive Multifocal Leukoencephalopathy
NEJM 350:1884-1893, Case 14-2004, 2004
Favorable Outcome of Ischemic Stroke in Patients Pretreated with Statins
Stroke 35:1117-1123, Marti-Fabregas,J.,et al, 2004
Clinicopath Conf, Malignant Middle Cerebral Artery Infarction
NEJM 350:707-716, Case 5-2004, 2004
Magnesium for Acute Stroke (Intravenous Magnesium Efficacy in Stroke Trial):Randomised Controlled Trial
Lancet 363:439-445,414, Goldstein,L.B., 2004
Treatment-Induced Leukoencephalopathy in Primary CNS Lymphoma,A Clinical and Autopsy Study
Neurol 62:451-456, Lai,R.,et al, 2004
Neuroprotection in Parkinson Disease, Mysteries, Myths, and Misconceptions
JAMA 291:358-364, Schapira,A.H.V.&Olanow,C.W., 2004
Magnetic Resonance Imaging Improves Detection of Intracerebral Hemorrhage Over Computed Tomography after Intra-Arterial Thrombolysis
Stroke 35:491-495, Greer,D.M.,et al, 2004
Clinical and MRI Outcome after Autologous Hematoipoietic Stem Cell Transplantation in MS
Neurol 62:282-284,168, Saiz,A.,et al, 2004
Reversible Abnormalities of DWI in High-Altitude Cerebral Edema
Neurol 62:335-336, Wong,S.H.,et al, 2004
Babesiosis and HIV
Lancet 363:704, Froberg,M.K.,et al, 2004
MR Imaging in Toxoplasmosis Encephalitis After Bone Marrow Transplantation: Paucity of Enhancement Despite Fulminant Disease
AJNR 25:270-273, Ionita,C.,et al, 2004
Liver Injury Associated with the B-Interferons for MS
Neurol 62:628-631, Tremlett,H.L.,et al, 2004
Cognitive Functions in Survivors of Primary Central Nervous System Lymphoma
Neurol 62:548-555,532, Correa,D.D.,et al, 2004
Cognitive Status and Quality of Life After Treatment for Primary CNS Lymphoma
Neurol 62:544-547,532, Harder,H.,et al, 2004
Effects of Cholesterol-lowering with Simvastatin on Stroke and Other Major Vascular Events in 20 536 People with Cerebrovascular Disease or Other High-Risk Conditions
Lancet 363:757-767, Heart Protection Study Collaborative Group, 2004
Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Arch Neurol 61:346-350, Katzan,I.L.,et al, 2004
Association of Outcome with Early Stroke Treatment:Pooled Analysis of ATLANTIS, ECASS, and NINDS rt-PA Stroke Trials
Lancet 363:768-774, The ATLANTIS,ECASS,and NINDS rt-PA Study Group, 2004
Contrast Enhancement and Contrast Extravasation on Computed Tomography After Intra-Arterial Thrombolysis in Patients with Acute Ischemic Stroke
Stroke 35:876-881, Yoon,W.,et al, 2004
Combined Intravenous and Intra-Arterial Recanalization for Acute Ischemic Stroke:The Interventional Management of Stroke Study
Stroke 35:904-911, The IMS Study Investigators, 2004
Clinical and Radiological Predictors of Recanalisation and Outcome of 40 Patients with acute Basilar Artery Occlusion Treated with Intra-Arterial Thrombolysis
JNNP 75:857-862, Arnold,M.,et al, 2004
Hypercholesterolemia, HMG-CoA Reductase Inhibitors, and Risk of Intracerebral Hemorrhage
Stroke 35:1360-1364, Woo,D.,et al, 2004
Predictors of Hyperacute Clinical Worsening in Ischemic Stroke Patients Receiving Thrombolytic Therapy
Stroke 35:1903-1907, Leigh,R.,et al, 2004
Fatal Myositis Due to the Microsporidian Brachiola algerae, a Mosquito Pathogen
NEJM 351:42-47, Coyle,C.M.,et al, 2004
Methylprednisolone, Valacyclovir, or the Combination for Vestibular Neuritis
NEJM 351:354-361,322, Strupp,M.,et al, 2004
Chemotherapy as Initial Treatment in Gliomatosis Cerebri
Neurol 63:354-356, Levin,N.,et al, 2004
Initial Chemotherapy in Gliomatosis Cerebri
Neurol 63:270-275,204, Sanson,M.,et al, 2004
Prediction of Hospital Disposition After Thrombolysis for Acute Ischemic Stroke Using the National Institutes of Health Stroke Scale
Arch Neurol 61:1061-1064, Schlegel,D.J.,et al, 2004
Peripheral Neuropathy
Lancet 363:2151-2161, England,J.D. &Asbury,A.K., 2004
Remote Evaluation of Acute Ischemic Stroke in Rural Community Hospitals in Georgia
Stroke 35:1763-1768, Wang,S.,et al, 2004
Management of Myasthenia Gravis
Semin Neurol 24:41-48, Saperstein,D.S. &Barohn,R.J., 2004
Gadolinium-Enhanced CT Angiography of the Circle of Willis and Neck
AJNR 25:969-972, Henson,J.W.,et al, 2004
The Clinical-DWI Mismatch
Neurol 62:2187-2192, Davalos,A.,et al, 2004
Thalidomide Sensory Neurotoxicity
Neurol 62:2291-2293, Cavaletti,G.,et al, 2004
Clinical Implications of Benign Multiple Sclerosis: A 20-Year Population-Based Follow-Up Study
Ann Neurol 56:303-306, Pittock,S.J.,et al, 2004
Naturally Acquired West Nile Virus Encephalomyelitis in Transplant Recipients
Arch Neurol 61:1210-1220, Kleinschmidt-DeMasters,B.K.,et al, 2004
Hallucinations During Methylphenidate Therapy
Neurol 63:753-754, Gross-Tsur,V.,et al, 2004
Systemic Inflammatory Response Depends on Initial Stroke Severity but is Attenuated by Successful Thrombolysis
Stroke 35:2128, Audebert,H.J.,et al, 2004
Are There Time-Dependent Differences in Diffusion and Perfusion Within the First 6 Hours After Stroke Onset?
Stroke 35:2099, Fiehler,J.,et al, 2004
Salvage Therapy for Primary CNS Lymphoma with a Combination of Rituximab and Temozolomide
Neurol 63:901-903, Enting,R.H.,et al, 2004
Recent Developments in Bell's Palsy
BMJ 329:553-557, Holland,N.J. & Weiner,G.M., 2004
Bell's Palsy
NEJM 351:1323-1331, Gilden,D.H., 2004
Thrombylosis for Cerebral Vein and Dural Sinus Thrombosis
Stroke 35:2428, Ciccone,A.,et al, 2004
Findings From the Reanalysis of the NINDS Tissue Plasminogen Activator for Acute Ischemic Stroke Treatment Trial
Stroke 35:2418-2424, Ingall,T.J.,et al, 2004
Expanding the Range of Therapies for Acute Ischemic Stroke: The Early Experience of the Regional Stroke Center at Hartford Hospital
Connecticut Medicine 68:419-429, Silvernman,I.E.,et al, 2004
Interferon Beta-1a for Brain Tissue Loss in Patients at Presentation with Syndromes Suggestive of Multiple Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 364:1489-1496,1463, Filippi,M.,et al, 2004
Clinicopath Conf, Anaplastic Oligodendroglioma with Allelic Loss of Chromosomes 1p and 19q
NEJM 351:1875-1882, Case 33-2004, 2004
Sequential Combination of Intravenous Recombinant Tissue Plasminogen Activator and Intra-Arterial Urokinase in Acute Ischemic Stroke
AJNR 25:1470-1475, Lee,K.Y.,et al, 2004
Predictors of In-Hospital Mortality in Patients with Acute Ischemic Stroke Treated with Thrombolytic Therapy
JAMA 292:1831-1838, Heuschmann,P.U.,et al, 2004
Lack of Improvement in Patients with Acute Stroke After Treatment with Thrombolytic Therapy
JAMA 292:1839-1844, Saposnik,G.,et al, 2004